Top Markets
Coin of the day
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DPH
Rangering i aksjer #24501
Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the... Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.
Aksjekurs
$52.60
Sist synkronisert: 2024-01-15
Markedsverdi
$59.92M
Endring (1 dag)
6.81%
Endring (1 år)
0.00%
Land
GB
Handel Dechra Pharmaceuticals PLC (DPH)

Kategori

P/B-forhold for Dechra Pharmaceuticals PLC (DPH)
P/B-forhold per 2026 TTM: 0
Ifølge Dechra Pharmaceuticals PLC sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Dechra Pharmaceuticals PLC fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
31.0864 -
US
7.4766 -
US
-74.4354 -
US
8.4776 -
CH
8.008 -
US